Skip to main content

A clearer way to understand peptides.

Research listings · Peptides

DSIP (delta sleep-inducing peptide) research listings: prices and suppliers

Research materials and consumer products belong to different categories. A listing, laboratory report, or research-use label does not establish suitability for personal use.

We have no commercial relationship with suppliers on this page. Offers are sorted by price per mg; commission never changes the order.

Prices observed weekly · last check · How we check prices →

Lowest current at 15 mg × 1 vial$3.24 / mg · $48.58Peak Lab Peptides · checked 5 days ago

Listings at 15 mg × 1 vial

Current DSIP (delta sleep-inducing peptide) listings at 15 mg × 1 vial (column headings with arrows can be selected to sort)
Supplier link
Peak Lab PeptidesProduct page includes use or preparation wording15 mg × 1 vial$48.58$3.24 / mgIn stock5 d agoNot linkedView product details (opens in a new tab)No commercial relationship
  • Peak Lab PeptidesProduct page includes use or preparation wordingIn stock

    DSIP (delta sleep-inducing peptide) · 15 mg × 1 vial

    $48.58$3.24 / mg

    Checked · 5 days ago

    Lab report: Not linked

By size

Every package size we track for DSIP (delta sleep-inducing peptide). Current means seen in the last 8 days.

DSIP (delta sleep-inducing peptide) listings by package size (column headings with arrows can be selected to sort)
2 mg × 1 vial$24.95$12.48 / mg1 / 11
5 mg × 1 vial$23.49$4.70 / mg9 / 98
10 mg × 1 vial$39.88$3.99 / mg4 / 64
15 mg × 1 vial$48.58$3.24 / mg1 / 11
2 mg × 10 vials——0 / 10
10 mg × 10 vials$439.00$4.39 / mg1 / 11

Research context

From our own records, with the date each was last checked.

FDA approval
No approved drug product with this ingredient listed in Drugs@FDA (data updated 2026-11-02)Checked
503A / 503B compounding
Formerly 503A category 2 (as emideltide); nominations withdrawn. Not in any 503A category on FDA's 2026-05-14 listChecked
Advisory committee (PCAC)
PCAC discussed emideltide (DSIP) and its acetate on 2026-07-24 (uses reviewed: opioid withdrawal, chronic insomnia, narcolepsy); FDA's briefing weighed against listingChecked
Rulemaking / enforcement
No proposed or final rule found in the Federal Register (search on 2026-11-03); the only match is FDA's 2026 PCAC meeting noticeChecked
Identity
Formula C35H48N10O15 · MW 848.8 g/mol · CAS 62568-57-4Sequence WAGGDASGESource record Checked

How we check prices · Offers are matched to our catalogue by an editor before they appear; a listing is not an endorsement.